In addition, an ongoing, long-term extension trial ( NCT01500551 , https://classic.clinicaltrials.gov/ct2/show/NCT01500551?term=01500551&draw=2&rank=1 ) might be significant in observing the long-term safety of tofacitinib in paediatric patients.
← all excerpts
Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review.
1
—
—